SynthesisFrontiers in psychiatry2026
Effectiveness of mindfulness-based stress reduction for depression in post-stroke patients: a systematic review and meta-analysis.
Synthesis in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression is a common complication after stroke. Although prior studies suggest that mindfulness-based stress reduction (MBSR) may alleviate depressive symptoms in post-stroke patients, the evidence remains inconclusive. This meta-analysis aimed to synthesize randomized controlled trials (RCTs) to evaluate the effects of MBSR on depressive symptoms after stroke. Methods: PubMed, Web of Science, Embase, the Cochrane Library, PsycINFO, CNKI, and Wanfang Data were searched from inception to October 2025. Eligible studies were RCTs assessing the effects of MBSR on depressive symptoms in post-stroke patients. Two reviewers independently performed study selection, data extraction, and risk-of-bias assessment. Results: Eight RCTs involving 469 participants were included. Meta-analysis using the standardized mean difference (SMD) showed that MBSR significantly reduced depressive symptoms compared with control conditions (SMD = -0.96, 95% CI: -1.35 to -0.58, P < 0.001), with substantial heterogeneity (I² = 71%). The 95% prediction interval ranged from -1.95 to 0.03, indicating that the true effect may be negligible in some future settings. In subgroup analyses, trials conducted in Asia demonstrated significant benefits (SMD = -1.27, 95% CI: -1.60 to -0.93, P < 0.001), whereas trials conducted in other regions did not reach statistical significance (SMD = -0.31, 95% CI: -0.74 to 0.13, P = 0.17); the difference between subgroups was significant (Q-between = 11.77, P = 0.0006). Participants receiving MBSR during the stable post-stroke phase showed significant improvement (SMD = -1.02, 95% CI: -1.57 to -0.47, P < 0.001), whereas those treated during the acute phase did not (SMD = -0.80, 95% CI: -1.88 to 0.27, P = 0.14); the subgroup difference was not significant (Q-between = 0.13, P = 0.7204). Conclusions: MBSR may reduce depressive symptoms after stroke, particularly during the stable phase. However, the overall certainty of evidence was rated as low due to high risk of bias, substantial heterogeneity, and imprecision. Well-designed RCTs with longer follow-up are warranted to confirm these results. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420251271797.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.